THE TRINITY CHALLENGE

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  +55.7%

  £1,511,326 → £2,353,209

• Net assets

  -7.1%

  £1,586,365 → £1,474,064

• Employees

  +300%

  1 → 4

• Wages

  +161.6%

  £91,777 → £240,124

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Moore Kingston Smith LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“It is the Board's view that the reserves of the Trinity Challenge are such that it will continue to meet its financial obligations to pay prize winners' grants and innovation support costs in full for the first two challenges. Additionally, the Trustees will not make expenditure commitments in excess of committed income for the third public Challenge. As such, these accounts and the accompanying report have been created on a going concern basis.”

Significant events

• “Our charity was set up during COVID-19 - a pandemic that so painfully exposed the consequences of inadequate data systems and unpreparedness.”
• “In 2024, we focused on Antimicrobial Resistance (AMR).”
• “Our second global innovation competition, the Trinity Challenge on Antimicrobial Resistance, drew an extraordinary 285 applications from 57 countries.”
• “We have launched a series of engagements with young people, to raise awareness and galvanise action on AMR. Through our inaugural Youth Summit and Competition, we reached over 400 young people.”
• “A unique collaboration with the Stanford Deliberative Polling Lab engaged 2,500 individuals across six middle-income countries to better understand public attitudes on AMR.”
• “The Trinity Challenge on Antimicrobial Resistance concluded in 2024. The winning projects launched in November and will continue to 2026/7.”
• “In 2024, VaccineLedger achieved a groundbreaking milestone with its nationwide deployment in Bangladesh. This implementation is estimated to digitally track 100 million vaccine doses annually.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.